Sirukumab (INN, USAN) (developmental code name CNTO-136, tentative brand name Plivensia) is a human monoclonal antibody designed for the treatment of...
4 KB (259 words) - 04:48, 6 July 2024
arthritis : clazakizumab, olokizumab, sarilumab and sirukumab have all reported encouraging phase 2 results. Sirukumab is in multiple phase 3 trials.: Table1 Agents...
12 KB (1,289 words) - 19:20, 4 December 2023
ARGX-109 Clazakizumab Elsilimomab mAb 1339 Olokizumab Sarilumab Siltuximab Sirukumab Tocilizumab Levilimab IL-7 Agonists: Interleukin 7 IL-8 See CXCR1 (IL-8Rα)...
22 KB (1,789 words) - 04:29, 16 July 2024
Efficacy and Safety Study of Sirukumab in Participants With Major Depressive Disorder." at ClinicalTrials.gov "Sirukumab - Janssen Biotech". AdisInsight...
63 KB (7,473 words) - 02:17, 23 July 2024
ARGX-109 Clazakizumab Elsilimomab mAb 1339 Olokizumab Sarilumab Siltuximab Sirukumab Tocilizumab Levilimab IL-7 Agonists: Interleukin 7 IL-8 See CXCR1 (IL-8Rα)...
17 KB (1,245 words) - 04:39, 17 August 2024
siponimod (INN) sipuleucel-T (USAN) siratiazem (INN) sirolimus (INN) sirukumab (INN) sisomicin (INN) sitafloxacin (INN) sitagliptin (USAN) sitalidone...
4 KB (264 words) - 05:09, 18 July 2024
Siltuximab L04AC12 Brodalumab L04AC13 Ixekizumab L04AC14 Sarilumab L04AC15 Sirukumab L04AC16 Guselkumab L04AC17 Tildrakizumab L04AC18 Risankizumab L04AC19...
3 KB (367 words) - 15:37, 25 January 2024
ARGX-109 Clazakizumab Elsilimomab mAb 1339 Olokizumab Sarilumab Siltuximab Sirukumab Tocilizumab Levilimab IL-7 Agonists: Interleukin 7 IL-8 See CXCR1 (IL-8Rα)...
31 KB (2,444 words) - 00:18, 6 August 2024
ARGX-109 Clazakizumab Elsilimomab mAb 1339 Olokizumab Sarilumab Siltuximab Sirukumab Tocilizumab Levilimab IL-7 Agonists: Interleukin 7 IL-8 See CXCR1 (IL-8Rα)...
22 KB (2,581 words) - 20:03, 21 June 2024
Risankizumab Ritlecitinib Rozanolixizumab Sarilumab Satralizumab Siltuximab Siponimod Sirukumab Spesolimab Sutimlimab Tildrakizumab Tofacitinib Upadacitinib...
7 KB (299 words) - 13:45, 27 April 2024
ARGX-109 Clazakizumab Elsilimomab mAb 1339 Olokizumab Sarilumab Siltuximab Sirukumab Tocilizumab Levilimab IL-7 Agonists: Interleukin 7 IL-8 See CXCR1 (IL-8Rα)...
43 KB (3,662 words) - 19:35, 12 July 2024
ARGX-109 Clazakizumab Elsilimomab mAb 1339 Olokizumab Sarilumab Siltuximab Sirukumab Tocilizumab Levilimab IL-7 Agonists: Interleukin 7 IL-8 See CXCR1 (IL-8Rα)...
14 KB (1,037 words) - 04:45, 6 July 2024
ARGX-109 Clazakizumab Elsilimomab mAb 1339 Olokizumab Sarilumab Siltuximab Sirukumab Tocilizumab Levilimab IL-7 Agonists: Interleukin 7 IL-8 See CXCR1 (IL-8Rα)...
24 KB (2,070 words) - 07:13, 15 March 2024
Briakinumab Canakinumab Fezakinumab Fletikumab Guselkumab Secukinumab Sirukumab Tralokinumab Ustekinumab Humanized Anrukinzumab Bimekizumab Clazakizumab...
38 KB (4,304 words) - 10:14, 21 July 2024
ARGX-109 Clazakizumab Elsilimomab mAb 1339 Olokizumab Sarilumab Siltuximab Sirukumab Tocilizumab Levilimab IL-7 Agonists: Interleukin 7 IL-8 See CXCR1 (IL-8Rα)...
14 KB (1,147 words) - 07:33, 11 August 2024
ARGX-109 Clazakizumab Elsilimomab mAb 1339 Olokizumab Sarilumab Siltuximab Sirukumab Tocilizumab Levilimab IL-7 Agonists: Interleukin 7 IL-8 See CXCR1 (IL-8Rα)...
22 KB (2,510 words) - 04:11, 12 August 2024
ARGX-109 Clazakizumab Elsilimomab mAb 1339 Olokizumab Sarilumab Siltuximab Sirukumab Tocilizumab Levilimab IL-7 Agonists: Interleukin 7 IL-8 See CXCR1 (IL-8Rα)...
16 KB (1,451 words) - 18:24, 2 August 2024
ARGX-109 Clazakizumab Elsilimomab mAb 1339 Olokizumab Sarilumab Siltuximab Sirukumab Tocilizumab Levilimab IL-7 Agonists: Interleukin 7 IL-8 See CXCR1 (IL-8Rα)...
5 KB (272 words) - 03:23, 14 August 2024
ARGX-109 Clazakizumab Elsilimomab mAb 1339 Olokizumab Sarilumab Siltuximab Sirukumab Tocilizumab Levilimab IL-7 Agonists: Interleukin 7 IL-8 See CXCR1 (IL-8Rα)...
49 KB (6,005 words) - 16:30, 10 June 2024
ARGX-109 Clazakizumab Elsilimomab mAb 1339 Olokizumab Sarilumab Siltuximab Sirukumab Tocilizumab Levilimab IL-7 Agonists: Interleukin 7 IL-8 See CXCR1 (IL-8Rα)...
43 KB (5,000 words) - 13:28, 1 July 2024
ARGX-109 Clazakizumab Elsilimomab mAb 1339 Olokizumab Sarilumab Siltuximab Sirukumab Tocilizumab Levilimab IL-7 Agonists: Interleukin 7 IL-8 See CXCR1 (IL-8Rα)...
40 KB (4,858 words) - 14:50, 21 July 2024
ARGX-109 Clazakizumab Elsilimomab mAb 1339 Olokizumab Sarilumab Siltuximab Sirukumab Tocilizumab Levilimab IL-7 Agonists: Interleukin 7 IL-8 See CXCR1 (IL-8Rα)...
11 KB (813 words) - 11:58, 6 August 2024
ARGX-109 Clazakizumab Elsilimomab mAb 1339 Olokizumab Sarilumab Siltuximab Sirukumab Tocilizumab Levilimab IL-7 Agonists: Interleukin 7 IL-8 See CXCR1 (IL-8Rα)...
13 KB (1,523 words) - 19:27, 26 June 2024
ARGX-109 Clazakizumab Elsilimomab mAb 1339 Olokizumab Sarilumab Siltuximab Sirukumab Tocilizumab Levilimab IL-7 Agonists: Interleukin 7 IL-8 See CXCR1 (IL-8Rα)...
14 KB (1,578 words) - 14:00, 26 February 2024
ARGX-109 Clazakizumab Elsilimomab mAb 1339 Olokizumab Sarilumab Siltuximab Sirukumab Tocilizumab Levilimab IL-7 Agonists: Interleukin 7 IL-8 See CXCR1 (IL-8Rα)...
20 KB (2,192 words) - 23:02, 27 November 2023
ARGX-109 Clazakizumab Elsilimomab mAb 1339 Olokizumab Sarilumab Siltuximab Sirukumab Tocilizumab Levilimab IL-7 Agonists: Interleukin 7 IL-8 See CXCR1 (IL-8Rα)...
18 KB (2,082 words) - 08:54, 18 March 2024
ARGX-109 Clazakizumab Elsilimomab mAb 1339 Olokizumab Sarilumab Siltuximab Sirukumab Tocilizumab Levilimab IL-7 Agonists: Interleukin 7 IL-8 See CXCR1 (IL-8Rα)...
13 KB (1,675 words) - 00:18, 14 December 2023
ARGX-109 Clazakizumab Elsilimomab mAb 1339 Olokizumab Sarilumab Siltuximab Sirukumab Tocilizumab Levilimab IL-7 Agonists: Interleukin 7 IL-8 See CXCR1 (IL-8Rα)...
24 KB (3,043 words) - 22:14, 16 June 2024
ARGX-109 Clazakizumab Elsilimomab mAb 1339 Olokizumab Sarilumab Siltuximab Sirukumab Tocilizumab Levilimab IL-7 Agonists: Interleukin 7 IL-8 See CXCR1 (IL-8Rα)...
18 KB (1,212 words) - 07:10, 18 July 2024
ARGX-109 Clazakizumab Elsilimomab mAb 1339 Olokizumab Sarilumab Siltuximab Sirukumab Tocilizumab Levilimab IL-7 Agonists: Interleukin 7 IL-8 See CXCR1 (IL-8Rα)...
9 KB (587 words) - 20:04, 20 December 2023